Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03992131
Title A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Patients With a Solid Tumor (SEASTAR)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Clovis Oncology, Inc.

ovarian cancer

Advanced Solid Tumor

transitional cell carcinoma

triple-receptor negative breast cancer


Lucitanib + Rucaparib

Rucaparib + Sacituzumab govitecan-hziy

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST